American Cryostem (American Cryostem) Cash And Cash Equivalents : $0.00 Mil (As of Jun. 2022)

View and export this data going back to 2010. Start your Free Trial

What is American Cryostem Cash And Cash Equivalents?

American Cryostem's quarterly cash and cash equivalents declined from Dec. 2021 ($0.10 Mil) to Mar. 2022 ($0.02 Mil) but then stayed the same from Mar. 2022 ($0.02 Mil) to Jun. 2022 ($0.00 Mil).

American Cryostem's annual cash and cash equivalents increased from Sep. 2019 ($0.02 Mil) to Sep. 2020 ($0.04 Mil) but then declined from Sep. 2020 ($0.04 Mil) to Sep. 2021 ($0.01 Mil).

American Cryostem Cash And Cash Equivalents Historical Data

The historical data trend for American Cryostem's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Cryostem Cash And Cash Equivalents Chart

American Cryostem Annual Data

Trend

Sep12

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Cash And Cash Equivalents

Get a 7-Day Free Trial

0.41

0.07

0.02

0.04

0.01

American Cryostem Quarterly Data
	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22
Cash And Cash Equivalents	Get a 7-Day Free Trial															0.01	0.01	0.10	0.02	-

American Cryostem Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

American Cryostem (OTCPK:CRYO) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

American Cryostem Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of American Cryostem's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

American Cryostem (American Cryostem) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » American Cryostem Corp (OTCPK:CRYO) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

N/A

Address

1 Meridian Road, Suite 5, Eatontown, NJ, USA, 07724

Website

http://www.americancryostem.com

American Cryostem Corp is a biotechnology company which standardizes adipose tissue-derived technologies (Adult Stem Cells) for the fields of Regenerative and Personalized Medicine. The company acts as an innovator of adipose tissue and stem cell platform technologies. It provides the clinical grade, adipose tissue and adult stem cell collection, processing, and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.

Executives

John S Arnone	director, officer: Chairman	111 GREAT NECK RD, GREAT NECK NY 11021
Anthony Francis Dudzinski	director, officer: COO	188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Acs Global, Inc.	10 percent owner	188 E. BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Christopher Joseph Neill	10 percent owner	188 EAST BERGEN PLACE, SUITE 204, RED BANK NJ 07701
Hector Medina	director, 10 percent owner, officer: President and Director	1206 STAGECOACH TRAIL LOOP, CHULA VISTA CA 91915